Level C· Early human research exploring benefitsRetrospective StudyPubMed

Uniform Treatment Protocol With Hybrid Stromal Vascular Fraction and Platelet-Rich Plasma on Micro-Fat Grafting With Facelifting: A Preliminary Retrospective 3D Vectra Observational Study.

Sasaki G.

Retrospective Study on Face & Skin, Hip, published in Aesthet Surg J Open Forum (2026) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Retrospective Study
Journal
Aesthet Surg J Open Forum (2026)
Country
England
Reported sample size
—
Source database
PubMed
PMID
42582686
DOI
10.1093/asjof/ojag133

Abstract (original English)

Hybrid stromal vascular fraction (SVF), a combination of mechanical SVF (M-SVF) and stromal vascular matrix (M-SVM) fraction, is an alternative method to overcome limitations of low cell counts by conventional mechanical and enzymatic methods. The aim of this report was to observe the volume retention in facial fat grafts enhanced with hybrid M-SVF and platelets in pure platelet-rich plasma (P-PRP). Using a 5:1 v/v ratio, proportional volumes of micro-fat to proportional volumes and quantitative cell counts of M-SVF/M-SVM and PRP were delivered to palpebral-malar groove/malar fat pad units and evaluated by Vectra Analysis for volumetric changes over 12 months. Collective analysis of 9 female patients (average age: 65.6 years) revealed the percentage volume retention increased from baseline to 3 months (54.9%), then progressively declined to its nadir at 5 to 7 months (38.4%), then rebounded to peak percentage values at 10 to 12 months (69.5%), P > .05. Investigators' ratings on the Investigator Global Assessment Improvement Scale scores are assessed. There were no reported long-term side effects or complications. The application of M-SVF/M-SVM and platelets supported micro-fat grafting with simultaneous facelifting (necklifting) in a safe manner for patients older than 55 years of age in this preliminary study. However, the hypothesis-generated associations of SVF/SVM and plate

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research